MediPharm was founded in Canada in 2015 with the mission to manufacture products extracted from cannabis to the highest-quality standard for global distribution. Today, we are bound by that same principle.
MediPharm’s manufacturing facility is in a light industrial area which complies with the City’s zoning by-laws. As per Health Canada regulations it is located well away from any residential and school zones. Our facilities have been purpose-built for cannabis production. MediPharm received its Health Canada license for cannabis oil production in March 2018 and has been operational since June 2018. Phase One of our facility has a manufacturing capacity to extract over 100,000 kg of dry cannabis annually with operational space and funded capacity to extract over 250,000 kg of dry cannabis annually by Q4 2018.